Your browser is no longer supported. Please, upgrade your browser.
MEDP Medpace Holdings, Inc. daily Stock Chart
Medpace Holdings, Inc.
Index- P/E33.73 EPS (ttm)2.91 Insider Own23.90% Shs Outstand36.02M Perf Week4.93%
Market Cap3.51B Forward P/E27.48 EPS next Y3.57 Insider Trans0.00% Shs Float26.91M Perf Month11.96%
Income109.90M PEG5.62 EPS next Q0.41 Inst Own82.90% Short Float9.73% Perf Quarter18.12%
Sales891.10M P/S3.94 EPS this Y35.20% Inst Trans0.16% Short Ratio9.51 Perf Half Y16.53%
Book/sh19.93 P/B4.93 EPS next Y54.01% ROA10.10% Target Price88.40 Perf Year56.94%
Cash/sh3.75 P/C26.17 EPS next 5Y6.00% ROE15.70% 52W Range58.72 - 109.09 Perf YTD16.80%
Dividend- P/FCF17.89 EPS past 5Y54.40% ROI14.20% 52W High-7.41% Beta1.22
Dividend %- Quick Ratio0.90 Sales past 5Y21.40% Gross Margin28.70% 52W Low72.02% ATR3.36
Employees3600 Current Ratio0.90 Sales Q/Q15.00% Oper. Margin15.40% RSI (14)70.66 Volatility2.58% 3.75%
OptionableYes Debt/Eq0.00 EPS Q/Q47.90% Profit Margin12.30% Rel Volume0.68 Prev Close98.18
ShortableYes LT Debt/Eq0.00 EarningsJul 27 AMC Payout0.00% Avg Volume275.17K Price101.01
Recom2.60 SMA2010.41% SMA5014.19% SMA20020.90% Volume118,983 Change2.88%
Jun-08-20Upgrade Robert W. Baird Underperform → Neutral $83
May-13-20Downgrade Wolfe Research Outperform → Peer Perform
Apr-30-20Upgrade SunTrust Sell → Hold $85
Apr-20-20Downgrade Robert W. Baird Neutral → Underperform $77
Mar-17-20Downgrade SunTrust Hold → Sell
Jan-27-20Downgrade SunTrust Buy → Hold $85 → $87
Oct-31-18Upgrade SunTrust Hold → Buy
Sep-17-18Initiated SunTrust Hold $63
Jul-31-18Upgrade William Blair Mkt Perform → Outperform
Nov-01-17Downgrade William Blair Outperform → Mkt Perform
Sep-29-17Initiated Raymond James Mkt Perform
Jul-10-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Jun-23-20 11:08PM  
Jun-16-20 08:35PM  
May-26-20 04:05PM  
May-18-20 04:05PM  
May-15-20 03:06PM  
May-14-20 08:58AM  
May-01-20 09:38AM  
Apr-29-20 06:31PM  
Apr-28-20 07:05PM  
Apr-13-20 06:00AM  
Apr-05-20 04:27PM  
Apr-03-20 04:05PM  
Mar-26-20 06:51AM  
Mar-23-20 12:29PM  
Mar-15-20 10:28AM  
Mar-11-20 04:32PM  
Mar-06-20 03:26PM  
Mar-04-20 04:56PM  
Feb-26-20 09:34AM  
Feb-25-20 07:00AM  
Feb-24-20 06:25PM  
Jan-27-20 02:31PM  
Jan-08-20 10:39AM  
Jan-03-20 11:37AM  
Dec-24-19 05:34AM  
Dec-08-19 07:24PM  
Dec-05-19 02:24PM  
Nov-13-19 06:58AM  
Nov-01-19 07:36AM  
Oct-31-19 04:00PM  
Oct-28-19 05:55PM  
Oct-26-19 10:43PM  
Oct-21-19 12:31PM  
Oct-01-19 09:31AM  
Sep-27-19 09:28AM  
Sep-26-19 07:51AM  
Sep-25-19 10:17AM  
Sep-24-19 04:05PM  
Sep-09-19 08:59AM  
Sep-02-19 10:51AM  
Aug-29-19 09:01AM  
Aug-23-19 09:32AM  
Aug-20-19 09:35AM  
Aug-14-19 09:27AM  
Aug-13-19 04:05PM  
Aug-11-19 10:09AM  
Aug-07-19 10:45AM  
Aug-06-19 09:19AM  
Aug-05-19 10:32AM  
Jul-31-19 07:06AM  
Jul-30-19 05:23PM  
Jul-29-19 06:25PM  
Jul-27-19 02:32PM  
Jul-25-19 10:10AM  
Jul-24-19 06:38AM  
Jul-22-19 10:31AM  
Jul-19-19 09:15AM  
Jul-03-19 01:34PM  
Jun-28-19 05:00AM  
Jun-25-19 04:05PM  
Jun-18-19 08:18AM  
May-29-19 10:14AM  
May-21-19 04:05PM  
May-02-19 01:03PM  
Apr-30-19 04:08PM  
Apr-29-19 04:42PM  
Apr-26-19 12:38PM  
Apr-20-19 10:44AM  
Apr-09-19 07:15AM  
Apr-08-19 04:05PM  
Apr-02-19 10:13AM  
Mar-14-19 11:25AM  
Mar-12-19 11:32AM  
Mar-01-19 06:36AM  
Feb-26-19 04:30PM  
Feb-25-19 04:55PM  
Feb-22-19 10:07AM  
Feb-18-19 10:30AM  
Feb-08-19 04:34PM  
Feb-07-19 04:05PM  
Feb-05-19 06:15PM  
Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Medpace Investors, LLC10% OwnerMay 06Option Exercise14.413,51850,6947,790,766May 08 04:54 PM
Troendle August J.President & CEOMay 06Option Exercise14.413,51850,6947,790,766May 08 04:54 PM
Troendle August J.President & CEOJan 31Option Exercise14.6126,664389,5307,787,248Feb 04 04:11 PM
Medpace Investors, LLC10% OwnerJan 31Option Exercise14.6126,664389,5307,787,248Feb 04 04:12 PM
GEIGER JESSE JCFO & COO, Lab OperationsDec 20Sale84.0016,9481,423,6320Dec 23 04:10 PM
GEIGER JESSE JCFO & COO, Lab OperationsDec 19Sale82.0014,4001,180,80016,948Dec 23 04:10 PM
Troendle August J.President & CEONov 15Option Exercise15.341,07316,4557,760,584Nov 19 04:17 PM
Medpace Investors, LLC10% OwnerNov 15Option Exercise15.341,07316,4557,760,584Nov 19 04:15 PM
EWALD STEPHEN PGeneral Counsel & Corp. Secy.Oct 18Sale77.308,000618,4000Oct 22 04:11 PM
GEIGER JESSE JCFO & COO, Lab OperationsOct 15Sale80.009,600768,00031,348Oct 16 04:17 PM
GEIGER JESSE JCFO & COO, Lab OperationsOct 14Sale78.037,200561,81640,948Oct 16 04:17 PM
Troendle August J.President & CEOSep 24Option Exercise14.818,386124,1567,759,511Sep 26 04:24 PM
Medpace Investors, LLC10% OwnerSep 24Option Exercise14.818,386124,1567,759,511Sep 26 04:18 PM